Results 281 to 290 of about 4,713,645 (328)

Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin   +2 more
wiley   +1 more source

Correcting fast irregular motion in PET: Maximum-Likelihood Motion and Activity (MLMA) reconstruction

open access: yes
Santo RJ   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy